Loading...

Jinxin Fertility Group Limited

JXFGF•PNK
Healthcare
Medical - Care Facilities
$1.00
$0.72(257.14%)

Jinxin Fertility Group Limited (JXFGF) Stock Overview

Explore Jinxin Fertility Group Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap2.7B
P/E Ratio62.44
EPS (TTM)$0.02
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 Week$0.28
1 Month$0.28
3 Months$0.15
1 Year Target$0.12

JXFGF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Jinxin Fertility Group Limited (JXFGF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.12.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 62.44 and a market capitalization of 2.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for JXFGFStats details for JXFGF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for JXFGFAnalyst Recommendations details for JXFGF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.

CEO

Yang Dong

Employees

3,198

Headquarters

No. 301, North Jingsha Road, Chengdu

Founded

2021

Frequently Asked Questions

;